About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 40886 record(s)
Req # A-2016-000148
The records generated within Health Canada regarding the Attawapiskat crisis in HC from April 1, 2016 to April 26, 2016.Organization: Health Canada
December 2020
Req # A-2017-000314
The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for EPREX (Epoetin) by Janssen Inc.Organization: Health Canada
December 2020
Req # A-2017-001357
All correspondence at an Assistant Deputy Minister (ADM) level or above regarding medical cannabis re: smoke, topicals and edibles from April - June 2017.Organization: Health Canada
December 2020
Req # A-2020-000707
Adverse Reaction Reports (AERs). Report numbers: E2B_02748964, E2B_02978453, 000730851, E2B_02799042, E2B_02682822.Organization: Health Canada
December 2020
Req # A-2019-001583
All records detailing what was discussed at each meeting of the Deputy Ministers’ Breakfast (DMB) committee over the past six months.Organization: Health Canada
December 2020
Req # A-2020-001024
Heath Canada’s documents that discussed the 2015 scheduling initiative pertaining to 2C-phenthylamines--especially the intended scope of substituted phenethylamines, and nomenclature for the intended substituted phenethylamines.Organization: Health Canada
December 2020
Req # A-2020-000657
All records regarding this article in The Logic: "Canadian tech companies that pivoted to making ventilators drawing global interest".Organization: Health Canada
December 2020
Req # A-2019-000092
Adverse Reaction Reports (AERs) for VEDOLIZUMAB. Report numbers: 717972, 720568, E2B_02098024, E2B_02110651, E2B_02135149, E2B_02136657, E2B_02159265, E2B_02165562, E2B_02168390, E2B_02171111, E2B_02187319, E2B_02188869, E2B_02201833, E2B_02210945,…Organization: Health Canada
December 2020
Req # A-2019-001066
Adverse Reaction Reports (AERs). Report numbers: 000643741, E2B_01509440, E2B_01969476, E2B_02062978, E2B_01466237, E2B_02107619, 00071681, 000718241, E2B_01651619, E2B_00583874, E2B_02103075.Organization: Health Canada
December 2020
Req # A-2019-001267
Adverse Reaction Reports (AERs). Report numbers: 000725284, 000725318, 000725522, 000726063, 000726157.Organization: Health Canada
December 2020